Why Procter & Gamble’s Quieter Dividend Outpaces Johnson & Johnson’s Growth Story

Both Johnson and Johnson and Procter & Gamble just refreshed decades-long dividend streaks, but one company has a corporate event on the horizon that has derailed other legendary payout records before.

Published September 1, 2026, 9:05am ET · 3 min read

A dynamic graphic split into two halves, red on the left and blue on the right, with a large, glowing gold 'VS' symbol at the center, surrounded by lightning. The left red section features the Johnson & Johnson logo in script, followed by 'JOHNSON & JOHNSON' in bold text, and 'NYSE: JNJ' below, set against a background of red stock charts and an upward arrow. The right blue section displays the P&G logo, 'PROCTER & GAMBLE' in bold text, and 'NYSE: PG' below, against a backdrop of blue stock charts and an upward arrow. The '24/7 WALL ST' logo is visible in the bottom-left corner.
This graphic visually pits Johnson & Johnson against Procter & Gamble, highlighting the market competition between these two consumer staples titans and their strong stock performance. © 24/7 Wall St.

Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) and Procter & Gamble (NYSE:PG) both recently refreshed their long dividend records. J&J posted Q1 2026 revenue of $24.06 billion and P&G closed fiscal 2026 with core EPS of $6.89. One is heading into a spinoff while the other stays intact, and that structural difference defines the comparison.

How Each Payout Actually Landed This Cycle

J&J lifted its quarterly dividend to $1.34 per share, with an ex-date of August 25, 2026, and a September 8 payment. The trailing 12-month total is $5.28, with the forward annualized total at $5.36. Growth is doing the heavy lifting: Darzalex at $4.21 billion (+22.5%) and Tremfya at $2.05 billion (+68.3%) more than offset Stelara’s revenue erosion of 55.7%.

P&G paid $1.0885 per share on August 17, 2026, with forward annualized of $4.354. Fiscal 2026 organic sales grew more than 1%, and management returned over $15 billion to shareowners, including more than $10 billion in dividends. Growth, not coverage, is the concern.

Metric JNJ PG
Latest quarterly dividend $1.34 $1.0885
Forward annualized $5.36 $4.354
1-year price change +53.4% −4.9%

Where the Two Streaks Really Diverge

J&J is heading into a corporate event that has broken other long streaks. CFO Joe Wolk said the company is “on track for a mid-2027 separation” of DePuy Synthes, with more updates expected later in 2026. The precedent cuts both ways. The Kenvue separation in 2023 came and went without a rebase, and quarterly dividends rose from $1.13 in 2022 to $1.34 today. 3M’s payout did not survive its Solventum spinoff intact.

P&G has no such event. New CEO Shailesh Jejurikar said, “we continue to believe the strategy is right,” backing it with $2.8 billion of pre-tax productivity savings. Fiscal 2027 guidance still calls for $10 billion in dividends and roughly $5 billion in buybacks, absorbing a $1 billion after-tax commodity headwind.

A Price Paradox Investors Keep Missing

The stock with the quieter payout has been the worse performer. PG is up just 1.3% year to date, while JNJ has climbed 28.5% YTD. Pipeline strength, not payout policy, drove that gap. CEO Duato reminded investors that the company has 28 platforms each generating more than $1 billion in annual revenue.

Verdict

For a retirement income investor wondering which payout is less likely to be disturbed by a corporate action, the answer is P&G. No separation is planned, coverage is generous, and productivity is funding the raise. (If you want a broader shortlist of 50-year raisers screened by valuation, we put 10 of them in a free Dividend Kings report.)

PG analyst ratings
PG price target

J&J’s payout looks equally covered, with FY2025 operating cash flow of $24,530 million against dividends paid of $12,381 million, but the DePuy Synthes carve-out is exactly the type of event that has tested streaks before. One specific thing to watch is J&J’s Enterprise Business Review on December 8. If management reaffirms the dividend framework alongside the separation terms, the dividend streak will likely continue uninterrupted.

JNJ analyst ratings
JNJ price target

 

Contact [email protected] for any questions or corrections.

Trey Thoelcke

Trey has been an editor and author at 24/7 Wall St. for more than a decade, where he has published thousands of articles analyzing corporate earnings, dividend stocks, short interest, insider buying, private equity, and market trends. His comprehensive coverage spans the full spectrum of financial markets, from blue-chip stalwarts to emerging growth companies.

Beyond 24/7 Wall St., Trey has created and edited financial content for Benzinga and AOL's BloggingStocks, contributing additional hundreds of articles to the investment community. He previously oversaw the 24/7 Climate Insights site, managing editorial operations and content strategy, and currently oversees and creates content for My Investing News.

Trey's editorial expertise extends across multiple publishing environments. He served as production editor at Dearborn Financial Publishing and development editor at Kaplan, where he helped shape financial education materials. Earlier in his career, he worked as a writer-producer at SVE. His freelance editing portfolio includes work for prestigious clients such as Sage Publications, Rand McNally, the Institute for Supply Management, the American Library Association, Eggplant Literary Productions, and Spiegel.

Outside of financial journalism, Trey writes fiction and has been an active member of the writing community for years, overseeing a long-running critique group and moderating workshop sessions at regional conventions. He lives with his family in an old house in the Midwest.

All articles →